Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial Martin Reck , R. Kaiser , Anders Mellemgaard +11 more 2014 The Lancet Oncology 923 citations